CN107028601A - 一种测量受试者反应性充血的方法及设备 - Google Patents
一种测量受试者反应性充血的方法及设备 Download PDFInfo
- Publication number
- CN107028601A CN107028601A CN201710123346.4A CN201710123346A CN107028601A CN 107028601 A CN107028601 A CN 107028601A CN 201710123346 A CN201710123346 A CN 201710123346A CN 107028601 A CN107028601 A CN 107028601A
- Authority
- CN
- China
- Prior art keywords
- pressure
- cuff
- curve
- area
- arterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 63
- 206010020565 Hyperaemia Diseases 0.000 title claims abstract description 24
- 208000022064 reactive hyperemia Diseases 0.000 title claims abstract description 22
- 210000001367 artery Anatomy 0.000 claims abstract description 27
- 238000005259 measurement Methods 0.000 claims description 50
- 230000008859 change Effects 0.000 claims description 34
- 230000036772 blood pressure Effects 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 230000010247 heart contraction Effects 0.000 claims description 5
- 230000035488 systolic blood pressure Effects 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 3
- 230000008694 endothelial dysfunction Effects 0.000 abstract description 83
- 206010048554 Endothelial dysfunction Diseases 0.000 abstract description 82
- 201000010099 disease Diseases 0.000 abstract description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 24
- 238000011282 treatment Methods 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 12
- 230000002093 peripheral effect Effects 0.000 description 12
- 201000011461 pre-eclampsia Diseases 0.000 description 11
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 9
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 238000010606 normalization Methods 0.000 description 7
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 206010003210 Arteriosclerosis Diseases 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 210000002460 smooth muscle Anatomy 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 3
- 230000004872 arterial blood pressure Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003038 endothelium Anatomy 0.000 description 3
- 238000007620 mathematical function Methods 0.000 description 3
- 238000013160 medical therapy Methods 0.000 description 3
- 230000005995 skin dysfunction Effects 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010003658 Atrial Fibrillation Diseases 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000018262 Peripheral vascular disease Diseases 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000007211 cardiovascular event Effects 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000008753 endothelial function Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000002969 morbid Effects 0.000 description 2
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000005586 smoking cessation Effects 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 208000009206 Abruptio Placentae Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 201000005624 HELLP Syndrome Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 206010021138 Hypovolaemic shock Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 201000008532 placental abruption Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000016686 tic disease Diseases 0.000 description 1
- 230000006441 vascular event Effects 0.000 description 1
- 230000006438 vascular health Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0295—Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02141—Details of apparatus construction, e.g. pump units or housings therefor, cuff pressurising systems, arrangements of fluid conduits or circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
- A61B5/0225—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers the pressure being controlled by electric signals, e.g. derived from Korotkoff sounds
- A61B5/02255—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers the pressure being controlled by electric signals, e.g. derived from Korotkoff sounds the pressure being controlled by plethysmographic signals, e.g. derived from optical sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4842—Monitoring progression or stage of a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21336909P | 2009-06-02 | 2009-06-02 | |
| US61/213,369 | 2009-06-02 | ||
| CN201080024509XA CN102481106A (zh) | 2009-06-02 | 2010-06-02 | 使用节段体积描记法检测和评估反应性充血的方法和装置 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080024509XA Division CN102481106A (zh) | 2009-06-02 | 2010-06-02 | 使用节段体积描记法检测和评估反应性充血的方法和装置 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107028601A true CN107028601A (zh) | 2017-08-11 |
Family
ID=43221023
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710123346.4A Pending CN107028601A (zh) | 2009-06-02 | 2010-06-02 | 一种测量受试者反应性充血的方法及设备 |
| CN201080024509XA Pending CN102481106A (zh) | 2009-06-02 | 2010-06-02 | 使用节段体积描记法检测和评估反应性充血的方法和装置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080024509XA Pending CN102481106A (zh) | 2009-06-02 | 2010-06-02 | 使用节段体积描记法检测和评估反应性充血的方法和装置 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8708921B2 (enExample) |
| EP (1) | EP2437656B1 (enExample) |
| JP (1) | JP5689116B2 (enExample) |
| CN (2) | CN107028601A (enExample) |
| AU (1) | AU2010257159B2 (enExample) |
| CA (2) | CA2995279C (enExample) |
| ES (1) | ES2757847T3 (enExample) |
| WO (1) | WO2010141081A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180042490A1 (en) * | 2009-06-02 | 2018-02-15 | Cordex Systems, Inc | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
| US9788733B2 (en) | 2009-06-02 | 2017-10-17 | Cordex Systems, Inc. | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
| CA2995279C (en) | 2009-06-02 | 2020-12-15 | Cordex Systems, Inc. | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
| WO2012151583A1 (en) * | 2011-05-05 | 2012-11-08 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| US20140170069A1 (en) * | 2011-05-05 | 2014-06-19 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| US11129911B2 (en) | 2011-05-05 | 2021-09-28 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| MX2015012585A (es) * | 2013-03-13 | 2016-10-13 | Everist Genomics Inc | Dilatación regulada por flujo para determinar la edad vascular. |
| US20150080747A1 (en) * | 2013-06-28 | 2015-03-19 | Cardiovascular Systems, Inc. | Devices, systems and methods for locally measuring biological conduit and/or lesion compliance, opposition force and inner diameter of a biological conduit |
| US10471094B2 (en) | 2013-08-05 | 2019-11-12 | Cedars-Sinai Medical Center | Methods for reducing ischemia-reperfusion injury via targeted control of blood gases |
| US20170065189A1 (en) * | 2014-03-03 | 2017-03-09 | Promedica Health System, Inc. | Systems and methods for performing an objective analysis of air plethysmography waveform |
| JP6494669B2 (ja) * | 2014-03-11 | 2019-04-03 | コーデックス システムズ, インコーポレーテッドCordex Systems, Inc. | 分節プレスチモグラフィを用いて反応性充血を検出および評価する方法および装置 |
| US10945612B2 (en) | 2014-04-03 | 2021-03-16 | The Regents Of The University Of California | Assessing endothelial function using a blood pressure cuff |
| CN106793963B (zh) * | 2014-08-28 | 2020-07-21 | 皇家飞利浦有限公司 | 用于振荡法无创血压(nibp)测量的方法和用于nibp装置的控制单元 |
| US10939832B2 (en) * | 2015-02-11 | 2021-03-09 | Microlife Intellectual Property Gmbh | Device and method for measuring blood pressure and for indication of the presence of atrial fibrillation |
| JP6482412B2 (ja) | 2015-07-01 | 2019-03-13 | 浜松ホトニクス株式会社 | 粘弾特性取得装置、粘弾特性取得方法、粘弾特性取得プログラム、及びそのプログラムを記録する記録媒体 |
| EP3316766A4 (en) * | 2015-07-01 | 2019-01-30 | Everist Genomics, Inc. | SYSTEM AND METHOD FOR ASSESSING THE ENDOTHEL FUNCTION |
| WO2017031005A1 (en) | 2015-08-14 | 2017-02-23 | The Regents Of The University Of California | Assessing endothelial function and providing calibrated ufmd data using a blood pressure cuff |
| CN108430310B (zh) * | 2015-12-23 | 2022-03-01 | 皇家飞利浦有限公司 | 评估血压测量结果的可靠性的方法和用于实施该方法的装置 |
| JP6627502B2 (ja) * | 2015-12-28 | 2020-01-08 | オムロンヘルスケア株式会社 | 電子血圧計 |
| US11253522B2 (en) | 2018-04-28 | 2022-02-22 | The Regents Of The University Of California | Cancer treatment targeted to tumor adaptive responses to protein synthesis stress |
| EP3964124A1 (en) * | 2020-09-02 | 2022-03-09 | Koninklijke Philips N.V. | Method and apparatus for estimating the reliability of cardiac output measurements |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4984577A (en) * | 1989-03-20 | 1991-01-15 | Hewlett-Packard Company | Oscillometric non-invasive method for measuring blood pressure and apparatus for automated oscillometric blood pressure measuring |
| US5241963A (en) * | 1991-06-12 | 1993-09-07 | Florida Atlantic University Research Corp. | Method for detecting the onset and relative degree of atherosclerosis in humans |
| US6309359B1 (en) * | 1998-06-01 | 2001-10-30 | Michael D. Whitt | Method and apparatus for noninvasive determination of peripheral arterial lumenal area |
| US20020111554A1 (en) * | 2000-06-12 | 2002-08-15 | Drzewiecki Gary M. | Method and system for detecting vascular conditions using an occlusive arm cuff plethysmograph |
| CN1642475A (zh) * | 2002-03-28 | 2005-07-20 | 欧姆龙株式会社 | 电子血压计及电子血压计的血压测量方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5417220A (en) * | 1989-12-20 | 1995-05-23 | Critikon, Inc. | Peripheral arterial monitoring instruments |
| JPH06319707A (ja) * | 1993-05-13 | 1994-11-22 | Omron Corp | 電子血圧計 |
| US6152881A (en) * | 1999-03-29 | 2000-11-28 | Vasocor, Inc. | Calibrated measurement of blood vessels and endothelium after reactive hyperemia and method therefor |
| JP3393432B2 (ja) * | 2000-09-06 | 2003-04-07 | オムロン株式会社 | 電子血圧計 |
| EP1585424B1 (en) | 2000-10-23 | 2016-03-30 | Itamar Medical Ltd | Apparatus for non-invasively evaluating endothelial activity in a patient |
| JP3590583B2 (ja) * | 2000-12-28 | 2004-11-17 | フクダ電子株式会社 | 血管内皮機能測定装置 |
| US6733461B2 (en) * | 2002-08-01 | 2004-05-11 | Hypertension Diagnostics, Inc. | Methods and apparatus for measuring arterial compliance, improving pressure calibration, and computing flow from pressure data |
| US20070225614A1 (en) * | 2004-05-26 | 2007-09-27 | Endothelix, Inc. | Method and apparatus for determining vascular health conditions |
| US7390303B2 (en) * | 2003-09-30 | 2008-06-24 | Ehud Dafni | Assessment of vascular dilatation |
| WO2005069740A2 (en) * | 2004-01-27 | 2005-08-04 | Cardiometer Ltd. | Method and system for cardiovascular system diagnosis |
| JP4629430B2 (ja) * | 2004-12-28 | 2011-02-09 | フクダ電子株式会社 | 血管内皮機能測定装置 |
| US8197416B1 (en) * | 2005-08-19 | 2012-06-12 | Ravi Shankar | Pulsatile measurement of cardiac malfunction conditions |
| US7674231B2 (en) * | 2005-08-22 | 2010-03-09 | Massachusetts Institute Of Technology | Wearable pulse wave velocity blood pressure sensor and methods of calibration thereof |
| JP4144807B2 (ja) * | 2005-11-21 | 2008-09-03 | 株式会社志成データム | 血管硬化度測定装置および血圧測定装置 |
| RU2309668C1 (ru) * | 2006-02-20 | 2007-11-10 | Александр Сергеевич Парфенов | Способ неинвазивного определения функции эндотелия и устройство для его осуществления |
| JP5176020B2 (ja) * | 2007-03-02 | 2013-04-03 | 国立大学法人 名古屋工業大学 | 生体内管腔体評価装置 |
| JP2008272387A (ja) * | 2007-03-30 | 2008-11-13 | Hiroshima Univ | 血管粘弾性測定装置、血管粘弾性測定方法、プログラム、コンピュータ読み取り可能な記録媒体、大規模集積回路及びｆｐｇａ |
| JP5363795B2 (ja) | 2008-04-14 | 2013-12-11 | 国立大学法人広島大学 | 血管内皮機能評価装置及び血管内皮機能評価方法 |
| CA2995279C (en) | 2009-06-02 | 2020-12-15 | Cordex Systems, Inc. | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
-
2010
- 2010-06-02 CA CA2995279A patent/CA2995279C/en active Active
- 2010-06-02 CA CA2763890A patent/CA2763890C/en active Active
- 2010-06-02 WO PCT/US2010/001605 patent/WO2010141081A2/en not_active Ceased
- 2010-06-02 ES ES10783706T patent/ES2757847T3/es active Active
- 2010-06-02 US US12/792,504 patent/US8708921B2/en active Active
- 2010-06-02 CN CN201710123346.4A patent/CN107028601A/zh active Pending
- 2010-06-02 JP JP2012513936A patent/JP5689116B2/ja active Active
- 2010-06-02 AU AU2010257159A patent/AU2010257159B2/en active Active
- 2010-06-02 CN CN201080024509XA patent/CN102481106A/zh active Pending
- 2010-06-02 EP EP10783706.4A patent/EP2437656B1/en active Active
-
2014
- 2014-03-11 US US14/204,678 patent/US9668662B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4984577A (en) * | 1989-03-20 | 1991-01-15 | Hewlett-Packard Company | Oscillometric non-invasive method for measuring blood pressure and apparatus for automated oscillometric blood pressure measuring |
| US5241963A (en) * | 1991-06-12 | 1993-09-07 | Florida Atlantic University Research Corp. | Method for detecting the onset and relative degree of atherosclerosis in humans |
| US6309359B1 (en) * | 1998-06-01 | 2001-10-30 | Michael D. Whitt | Method and apparatus for noninvasive determination of peripheral arterial lumenal area |
| US20020111554A1 (en) * | 2000-06-12 | 2002-08-15 | Drzewiecki Gary M. | Method and system for detecting vascular conditions using an occlusive arm cuff plethysmograph |
| CN1642475A (zh) * | 2002-03-28 | 2005-07-20 | 欧姆龙株式会社 | 电子血压计及电子血压计的血压测量方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010257159A1 (en) | 2012-01-19 |
| EP2437656B1 (en) | 2019-11-20 |
| US8708921B2 (en) | 2014-04-29 |
| JP5689116B2 (ja) | 2015-03-25 |
| CA2995279C (en) | 2020-12-15 |
| US20100305459A1 (en) | 2010-12-02 |
| WO2010141081A2 (en) | 2010-12-09 |
| CA2763890C (en) | 2018-04-03 |
| CA2995279A1 (en) | 2010-12-09 |
| CN102481106A (zh) | 2012-05-30 |
| AU2010257159B2 (en) | 2015-03-26 |
| ES2757847T3 (es) | 2020-04-30 |
| US9668662B2 (en) | 2017-06-06 |
| US20140194754A1 (en) | 2014-07-10 |
| EP2437656A4 (en) | 2012-05-09 |
| EP2437656A2 (en) | 2012-04-11 |
| JP2012528671A (ja) | 2012-11-15 |
| CA2763890A1 (en) | 2010-12-09 |
| WO2010141081A3 (en) | 2011-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107028601A (zh) | 一种测量受试者反应性充血的方法及设备 | |
| US6994675B2 (en) | Non-invasive measurement of suprasystolic signals | |
| US7727157B2 (en) | Non-invasive measurement of suprasystolic signals | |
| US10226186B2 (en) | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography | |
| Rang et al. | Modelflow: a new method for noninvasive assessment of cardiac output in pregnant women | |
| CN106456028B (zh) | 使用节段体积描记术检测和评估反应性充血的方法和装置 | |
| HK1243610A1 (en) | Method and device for assessing reactive hyperemia | |
| HK1235645A1 (en) | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography | |
| AU2015202799A1 (en) | Method And Device For Detecting And Assessing Reactive Hyperemia Using Segmental Plethysmography | |
| HK1235645B (zh) | 使用节段体积描记术检测和评估反应性充血的方法和装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1243610 Country of ref document: HK |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170811 |